Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Pharmastrand AB
AB
Active
Org 5592253164
Husbytorpsvägen 31 C, 197 33
Bro
Retail sale of pharmaceutical products
·
NACE 4773
Est. 2019 · 6 years old
1-4 employees
Monitor
Share
Sweden
/
Companies
/
Retail sale of pharmaceutical products
/
Pharmastrand AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
6M
5M
3M
2M
0M
2020: 0M
0M
2020
2021: 3M
3M
2021
2022: 4M (+33% vs 2021)
4M
+33%
2022
2023: 4M (0% vs 2022)
4M
0%
2023
2024: 5M (+25% vs 2023)
5M
+25%
2024
EBITDA
SEK millions
1M
1M
1M
0M
0M
2020: 0M
0M
2020
2021: 0M
0M
2021
2022: 1M
1M
2022
2023: 1M (0% vs 2022)
1M
0%
2023
2024: 0M (-100% vs 2023)
0M
-100%
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
4 662
4 021
3 987
3 388
76
Staff expenses
—
—
—
—
—
EBITDA
352
919
502
148
−264
Depreciation & amort.
−177
−149
−140
−140
−0
EBIT
175
770
362
8
−264
Net financials
−4
−1
−1
−1
—
Profit before tax
111
559
361
7
−264
Tax
−40
−132
−22
−0
−0
Net profit
71
427
339
7
−264
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
1 452
2 139
2 093
2 149
1 536
Equity
631
809
382
43
36
Long-term debt
0
0
0
0
0
Short-term debt
551
1 120
1 711
2 106
1 500
Total debt
551
1 120
1 711
2 106
1 500
Financial ratios
5-year trend
EBITDA margin
7,6 %
This company
15,8 %
Market median
This company
Market median
52% below market
2020
2024
Equity ratio
43,5 %
This company
38,2 %
Market median
This company
Market median
14% above market
2020
2024
Return on equity
11,3 %
This company
18,4 %
Market median
This company
Market median
39% below market
2020
2024
Net profit margin
1,5 %
This company
8,1 %
Market median
This company
Market median
81% below market
2020
2024
Asset turnover
3,21×
This company
1,12×
Market median
This company
Market median
187% above market
2020
2024
Debt / equity
1,30×
This company
0,62×
Market median
This company
Market median
110% above market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2019-11-01 – 2020-12-31
View
PDF
More on Pharmastrand AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
